Management of sickle cell disease in patients undergoing cardiac surgery
Journal of Cardiac Surgery
Sickle cell disease is a life-limiting inherited hemoglobinopathy that poses inherent risk for surgical complications following cardiac operations. In this review, we discuss preoperative considerations, intraoperative decision-making, and postoperative strategies to optimize the care of a patient with sickle cell disease undergoing cardiac surgery.
Crawford TC, Carter MV, Patel RK, Suarez-Pierre A, Lin SZ, Magruder JT, Grimm JC, Cameron DE, Baumgartner WA, Mandal K. Management of sickle cell disease in patients undergoing cardiac surgery. J Card Surg. 2017 Feb;32(2):80-84. doi: 10.1111/jocs.13093. Epub 2017 Jan 16. PMID: 28093814.